Sanofi’s Toujeo met main objective in head-to-head study versus insulin degludec
Sanofi’s Toujeo® met the primary study objective in the first large head-to-head clinical trial1, called BRIGHT study, comparing Toujeo with insulin degludec. Sanofi plans to provide full results in 2018.
- Health & Medicine
- Men's Health
- Women's Health